Construction of a Tumor-Targeting Nanobubble with Multiple Scattering Interfaces and its Enhancement of Ultrasound Imaging
Zhengjun Ma,Yanmei Zhang,Yupu Zhu,Minxuan Cui,Yutao Liu,Yun-You Duan,Li Fan,Li Zhang
DOI: https://doi.org/10.2147/ijn.s462917
IF: 7.033
2024-05-23
International Journal of Nanomedicine
Abstract:Zhengjun Ma, 1 Yanmei Zhang, 1 Yupu Zhu, 2 Minxuan Cui, 2 Yutao Liu, 2 Yun-You Duan, 1 Li Fan, 2 Li Zhang 1 1 Department of Ultrasound Medicine, Tangdu Hospital, Air Force Medical University, Xi'an, People's Republic of China; 2 Department of Pharmaceutical Chemistry and Analysis, School of Pharmacy, Air Force Medical University, Xi'an, People's Republic of China Correspondence: Li Fan; Li Zhang, Email ; Introduction: Recently, nanobubbles (NBs) have gained significant traction in the field of tumor diagnosis and treatment owing to their distinctive advantages. However, the application of NBs is limited due to their restricted size and singular reflection section, resulting in low ultrasonic reflection. Methods: We synthesized a nano-scale ultrasound contrast agent (IR783-SiO 2 NPs@NB) by encapsulating SiO 2 nanoparticles in an IR783-labeled lipid shell using an improved film hydration method. We characterized its physicochemical properties, examined its microscopic morphology, evaluated its stability and cytotoxicity, and assessed its contrast-enhanced ultrasound imaging capability both in vitro and in vivo. Results: The results show that IR783-SiO 2 NPs@NB had a "donut-type" composite microstructure, exhibited uniform particle size distribution (637.2 ± 86.4 nm), demonstrated excellent stability (30 min), high biocompatibility, remarkable tumor specific binding efficiency (99.78%), and an exceptional contrast-enhanced ultrasound imaging capability. Conclusion: Our newly developed multiple scattering NBs with tumor targeting capacity have excellent contrast-enhanced imaging capability, and they show relatively long contrast enhancement duration in solid tumors, thus providing a new approach to the structural design of NBs. Keywords: ultrasound contrast agents, nanobubbles, CEUS, scattering cross-section, SiO 2 NPs The favorable properties of nanobubbles (NBs), such as their size and ease of modification, have now been exploited to implement a theranostic platform for cancer treatment. 1–4 NB backbone-based nanotechnologies are focusing on their fabrication as an ideal tool due to their capacity for passive targeting via the enhanced permeability and retention (EPR) effect 5,6 and active targeting by functionalizing specific targeting ligands on the surfaces of NBs while transporting and controlling drug or gene delivery, thereby offering therapeutic potential. 7–10 However, when applied as ultrasound contrast agents (UCA), NBs commonly exhibit lower contrast signals compared to microbubbles due to the reduced scattering cross-section of a single bubble. 2,11,12 Efforts towards increasing the echogenicity of NBs have also been made in several studies, such as introducing a phase-change gas as the core of NBs when the NBs expand into more echogenic microbubbles under certain conditions, 13–16 or building a rattle-type mesoporous silica nanostructure with two contributing interfaces. 17,18 Theoretically, UCA echogenicity is expressed as the sum of the scattering cross-section for a single microbubble. 19 The backscattering coefficient (BSC) can be used as a measure of the ultrasound energy scattered by the material, which correlates to the UCA echogenicity and the ultrasound contrast signal generated. 20 Studies indicate that UCA echogenicity is most dependent on the UCA size distribution and concentration. 19,21 The targeted NBs enable its enrichment and prolonged retention in tumor tissue; however, the reduction in size leads to a decrease in BSC, thereby compromising the contrast-enhanced ultrasound (CEUS) signals and accuracy compared to those achieved by microbubble contrast agents. In our previous studies, efforts towards NB backbone-based functionalization have been made for the sake of tumor-targeted imaging and therapy. 10,22,23 Although functional elements such as anti-HER2 antibodies, IR780 or IR783 were conjugated with NB to strengthen tumor-targeted CEUS, or even to facilitate bimodal imaging as part of both CEUS and optical imaging, the NBs constructed remained limited by their barely satisfactory echogenicity when applied as UCAs for ultrasonographic diagnoses. Inspired by the structure-based design concept of enhancing cross-section scattering within a single NB, we fabricated a novel-structured NB through coating numerous hollow-structured SiO 2 nanoparticles (NPs) on their inner surfaces so as to augment the reflection interface and thus ensure active tumor-specific targeting guided by IR783. The novel-structured NBs with a "donut-type" shape could serve as a tu -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology